The Goldman Sachs Group started coverage on shares of Rocket Pharmaceuticals (NASDAQ:RCKT – Free Report) in a report published on Tuesday, MarketBeat Ratings reports. The firm issued a neutral rating and a $39.00 price target on the biotechnology company’s stock. RCKT has been the topic of several other reports. UBS Group cut their price objective […]
Christopher Paul German Sells 368 Shares of Rhythm Pharmaceuticals, Inc (NASDAQ:RYTM) Stock theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
StockNews.com began coverage on shares of Bellicum Pharmaceuticals (NASDAQ:BLCM – Free Report) in a research note issued to investors on Sunday. The brokerage issued a sell rating on the biopharmaceutical company’s stock. Bellicum Pharmaceuticals Stock Down 6.6 % Shares of BLCM opened at $0.07 on Friday. The business’s 50 day moving average is $0.08 and […]
Founders Capital Management LLC Lowers Stock Holdings in Regeneron Pharmaceuticals, Inc (NASDAQ:REGN) kopsource.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kopsource.com Daily Mail and Mail on Sunday newspapers.
StockNews.com assumed coverage on shares of Bellicum Pharmaceuticals (NASDAQ:BLCM – Free Report) in a research note issued to investors on Sunday. The brokerage issued a sell rating on the biopharmaceutical company’s stock. Bellicum Pharmaceuticals Stock Down 6.6 % NASDAQ:BLCM opened at $0.07 on Friday. The stock’s 50-day simple moving average is $0.08 and its 200 […]